Clinical Trials in Illinois

Showing 10601-10620 of 16,913 trials

Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis

NCT00249002

This study is designed to confirm the safety of the proposed dose and schedule of ABI-007 for hemodialysis patients with vascular access device failure, and to obtain preliminary data on the effectiveness of such treatment.

Hemodialysis Graft Dysfunction

Celgene9 participantsStarted Nov 2005

Peoria, Illinois, United States • Shreveport, Louisiana, United States • Rochester, New York, United States +1 more locations

COMPLETEDPhase 251 miles

Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

NCT00761215

The purpose of the study is to determine the oral dosage of TR-701 to be used in Phase III studies in patients with complicated skin and skin structure infections.

Skin Diseases, InfectiousSkin Diseases, Bacterial

Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)192 participantsStarted Sep 2008

Dothan, Alabama, United States • Chula Vista, California, United States • Long Beach, California, United States +9 more locations

COMPLETEDPhase 3108 miles

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

NCT00269438

The purpose of this study is to establish the efficacy and safety of a new tablet formulation and dosing regimen of balsalazide disodium dosed twice daily in achieving clinical improvement in subjects with mildly to moderately active ulcerative colitis after 8 weeks of therapy.

Ulcerative Colitis

Bausch Health Americas, Inc.225 participantsStarted Dec 2005

Birmingham, Alabama, United States • Mobile, Alabama, United States • Little Rock, Arkansas, United States +63 more locations

Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis

Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

Find Trials by Condition in Illinois

Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome

Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia

Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination

Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia

Safety of Intravenous Neridronic Acid in CRPS

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)

Diarrhea Predominant Irritable Bowel Syndrome in Females

Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study

Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer

Trial of Romidepsin and Bortezomib for Multiple Myeloma

Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly

A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma

Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)